154 related articles for article (PubMed ID: 34076794)
1. Radiopharmacokinetic modelling and radiation dose assessment of
Höllriegl V; Petoussi-Henss N; Hürkamp K; Ocampo Ramos JC; Li WB
EJNMMI Phys; 2021 Jun; 8(1):44. PubMed ID: 34076794
[TBL] [Abstract][Full Text] [Related]
2. Influence of human biokinetics of strontium on internal ingestion dose of 90Sr and absorbed dose of 89Sr to organs and metastases.
Li WB; Höllriegl V; Roth P; Oeh U
Radiat Environ Biophys; 2008 Apr; 47(2):225-39. PubMed ID: 18204850
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry of 223Ra-chloride: dose to normal organs and tissues.
Lassmann M; Nosske D
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):207-12. PubMed ID: 23053328
[TBL] [Abstract][Full Text] [Related]
4. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
Harrison J
J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
[TBL] [Abstract][Full Text] [Related]
5. Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.
Pacilio M; Ventroni G; De Vincentis G; Cassano B; Pellegrini R; Di Castro E; Frantellizzi V; Follacchio GA; Garkavaya T; Lorenzon L; Ialongo P; Pani R; Mango L
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):21-33. PubMed ID: 26266887
[TBL] [Abstract][Full Text] [Related]
6. ICRP Publication 133: The ICRP computational framework for internal dose assessment for reference adults: specific absorbed fractions.
Bolch WE; Jokisch D; Zankl M; Eckerman KF; Fell T; Manger R; Endo A; Hunt J; Kim KP; Petoussi-Henss N;
Ann ICRP; 2016 Nov; 45(2):5-73. PubMed ID: 29749258
[TBL] [Abstract][Full Text] [Related]
7. Biokinetic models for radiocaesium and its progeny.
Leggett RW
J Radiol Prot; 2013 Mar; 33(1):123-40. PubMed ID: 23296405
[TBL] [Abstract][Full Text] [Related]
8. Compartmental Model for
Taprogge J; Murray I; Gear J; Chittenden SJ; Parker CC; Flux GD
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):884-892. PubMed ID: 31349058
[TBL] [Abstract][Full Text] [Related]
9. Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy.
Bastiani I; McMahon SJ; Turner P; Redmond KM; McGarry CK; Cole A; O'Sullivan JM; Prise KM; Ainsbury L; Anderson R
Nucl Med Biol; 2022; 106-107():10-20. PubMed ID: 34968973
[TBL] [Abstract][Full Text] [Related]
10. Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer.
Carrasquillo JA; O'Donoghue JA; Pandit-Taskar N; Humm JL; Rathkopf DE; Slovin SF; Williamson MJ; Lacuna K; Aksnes AK; Larson SM; Scher HI; Morris MJ
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1384-93. PubMed ID: 23653243
[TBL] [Abstract][Full Text] [Related]
11. IDAC-Bio, A Software for Internal Dosimetry Based on the New ICRP Biokinetic Models and Specific Absorbed Fractions.
Andersson M; Leggett RW; Eckerman K; Almén A; Mattsson S
Health Phys; 2022 Aug; 123(2):165-172. PubMed ID: 35594483
[TBL] [Abstract][Full Text] [Related]
12. Inhalation dose assessment of indoor radon progeny using biokinetic and dosimetric modeling and its application to Jordanian population.
Al-Jundi J; Li WB; Abusini M; Tschiersch J; Hoeschen C; Oeh U
J Environ Radioact; 2011 Jun; 102(6):574-80. PubMed ID: 21477902
[TBL] [Abstract][Full Text] [Related]
13. Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [
Lassmann M; Eberlein U
Front Med (Lausanne); 2022; 9():1057373. PubMed ID: 36687439
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry of inhaled 219Rn progeny.
Issa H; Serge ABM
J Radiat Res; 2021 Mar; 62(2):226-235. PubMed ID: 33512484
[TBL] [Abstract][Full Text] [Related]
15. Examining Absorbed Doses of Indigenously Developed
Kamaldeep ; Wanage G; Sahu SK; Maletha P; Adnan A; Suman S; Basu S; Das T; Banerjee S
Cancer Biother Radiopharm; 2021 Apr; 36(3):292-304. PubMed ID: 32379495
[No Abstract] [Full Text] [Related]
16. Biodistribution and post-therapy dosimetric analysis of [
Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
EJNMMI Res; 2019 Nov; 9(1):102. PubMed ID: 31781962
[TBL] [Abstract][Full Text] [Related]
17. ICRP Publication 137: Occupational Intakes of Radionuclides: Part 3.
Paquet F; Bailey MR; Leggett RW; Lipsztein J; Marsh J; Fell TP; Smith T; Nosske D; Eckerman KF; Berkovski V; Blanchardon E; Gregoratto D; Harrison JD;
Ann ICRP; 2017 Dec; 46(3-4):1-486. PubMed ID: 29380630
[TBL] [Abstract][Full Text] [Related]
18. Radium Ra 223 dichloride in castration-resistant prostate cancer.
Joung JY; Ha YS; Kim IY
Drugs Today (Barc); 2013 Aug; 49(8):483-90. PubMed ID: 23977665
[TBL] [Abstract][Full Text] [Related]
19. Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone.
Takalkar A; Adams S; Subbiah V
Exp Hematol Oncol; 2014; 3():23. PubMed ID: 25243101
[TBL] [Abstract][Full Text] [Related]
20. 223Ra-Dichloride Response Evaluation Using 18F-Fluciclovine PET/CT and Bone Scintigraphy in a Patient With Castration-Resistant Metastatic Prostate Cancer.
Wang J; Kuker R; Serafini A
Clin Nucl Med; 2020 Nov; 45(11):e486-e488. PubMed ID: 32657864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
